U.S. Markets open in 4 hrs 35 mins

Alimera Sciences, Inc. (ALIM)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
1.295-0.035 (-2.632%)
At close: 3:59PM EDT
People also watch
PSDVACRXANTHAPRIEVOK
Full screen
Previous Close1.330
Open1.340
Bid1.200 x 600
Ask3.250 x 1000
Day's Range1.250 - 1.370
52 Week Range1.030 - 1.720
Volume180,855
Avg. Volume250,025
Market Cap89.42M
Beta2.81
PE Ratio (TTM)-3.30
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube13 days ago

    ETFs with exposure to Alimera Sciences, Inc. : September 9, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q2, 2017 By the Numbers : September 7, 2017
    Capital Cube15 days ago

    Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q2, 2017 By the Numbers : September 7, 2017

    Categories: Yahoo FinanceGet free summary analysis Alimera Sciences, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Alimera Sciences, Inc. – Ophthotech Corp., Eleven Biotherapeutics, Inc., Aerie Pharmaceuticals, Inc., Mateon Therapeutics, Inc., Regeneron Pharmaceuticals, Inc. and Insmed Incorporated (OPHT-US, EBIO-US, AERI-US, MATN-US, REGN-US and INSM-US) ... Read more (Read more...)

  • Thomson Reuters StreetEventslast month

    Edited Transcript of ALIM earnings conference call or presentation 3-Aug-17 1:00pm GMT

    Q2 2017 Alimera Sciences Inc Earnings Call